Alignment Healthcare Inc (ALHC) Shares Plummet Below 1-Year High

Alignment Healthcare Inc (NASDAQ: ALHC)’s stock price has plunge by -7.26relation to previous closing price of 4.82. Nevertheless, the company has seen a -4.89% plunge in its stock price over the last five trading sessions. Seeking Alpha reported 2024-02-28 that Alignment Healthcare, Inc. (ALHC) Q4 2023 Earnings Call Transcript

Is It Worth Investing in Alignment Healthcare Inc (NASDAQ: ALHC) Right Now?

Additionally, the 36-month beta value for ALHC is 1.30. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The public float for ALHC is 89.91M and currently, short sellers hold a 5.32% ratio of that float. The average trading volume of ALHC on April 04, 2024 was 912.25K shares.

ALHC’s Market Performance

The stock of Alignment Healthcare Inc (ALHC) has seen a -4.89% decrease in the past week, with a -17.22% drop in the past month, and a -47.35% fall in the past quarter. The volatility ratio for the week is 4.98%, and the volatility levels for the past 30 days are at 5.75% for ALHC. The simple moving average for the past 20 days is -10.23% for ALHC’s stock, with a -31.62% simple moving average for the past 200 days.

Analysts’ Opinion of ALHC

Many brokerage firms have already submitted their reports for ALHC stocks, with Barclays repeating the rating for ALHC by listing it as a “Underweight.” The predicted price for ALHC in the upcoming period, according to Barclays is $4.50 based on the research report published on March 06, 2024 of the current year 2024.

Piper Sandler, on the other hand, stated in their research note that they expect to see ALHC reach a price target of $6, previously predicting the price at $12. The rating they have provided for ALHC stocks is “Neutral” according to the report published on March 06th, 2024.

Stifel gave a rating of “Buy” to ALHC, setting the target price at $11 in the report published on January 24th of the current year.

ALHC Trading at -24.46% from the 50-Day Moving Average

After a stumble in the market that brought ALHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -51.40% of loss for the given period.

Volatility was left at 5.75%, however, over the last 30 days, the volatility rate increased by 4.98%, as shares sank -18.28% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -40.08% lower at present.

During the last 5 trading sessions, ALHC fell by -4.89%, which changed the moving average for the period of 200-days by -31.12% in comparison to the 20-day moving average, which settled at $4.93. In addition, Alignment Healthcare Inc saw -48.08% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at ALHC starting from Maroney Dawn Christine, who sale 10,151 shares at the price of $4.84 back on Mar 28 ’24. After this action, Maroney Dawn Christine now owns 1,976,097 shares of Alignment Healthcare Inc, valued at $49,131 using the latest closing price.

Kardes Hakan, the Chief Experience Officer of Alignment Healthcare Inc, sale 4,363 shares at $4.84 during a trade that took place back on Mar 28 ’24, which means that Kardes Hakan is holding 430,444 shares at $21,117 based on the most recent closing price.

Stock Fundamentals for ALHC

Current profitability levels for the company are sitting at:

  • -0.07 for the present operating margin
  • 0.11 for the gross margin

The net margin for Alignment Healthcare Inc stands at -0.08. The total capital return value is set at -0.39. Equity return is now at value -74.93, with -24.15 for asset returns.

Based on Alignment Healthcare Inc (ALHC), the company’s capital structure generated 0.52 points at debt to capital in total, while cash flow to debt ratio is standing at -0.34. The debt to equity ratio resting at 1.1. The interest coverage ratio of the stock is -6.02.

Currently, EBITDA for the company is -105.3 million with net debt to EBITDA at 0.31. When we switch over and look at the enterprise to sales, we see a ratio of 0.45. The receivables turnover for the company is 15.23for trailing twelve months and the total asset turnover is 3.08. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.84.


In conclusion, Alignment Healthcare Inc (ALHC) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts